Tourettes Syndrome: Clinical Trials

2 trials for Tourettes Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Completed 1

Follow Tourettes Syndrome: new trials by email Literature Review of Tourettes Syndrome trials Research Report on Tourettes Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Exposure and Response Prevention (ERP), Habit Reversal Training (HbRT, Psychoeducation and Supportive Intervention - Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal
Not applicableRecruitingUniversity College London Hospitals402026-07-082026-07-27
N-acetylcysteine (NAC) for Children With Tourette Syndrome
N-Acetylcysteine (NAC), Placebo - Tourettes Syndrome, Tic
Phase 2CompletedYale University312010-07-012017-02-10

Narrower conditions

Tic Disorders (2)  ·  Tourette Syndrome (2)  ·  Compulsive Personality Disorder (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Tics (1)

Broader conditions

Basal Ganglia Diseases (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Mental Disorders (2)  ·  Movement Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)  ·  Neurodevelopmental Disorders (2)  ·  Anxiety Disorders (1)  ·  Dyskinesias (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Acetylcysteine (1)

Sponsors

University College London Hospitals (1)  ·  Yale University (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Michael H. Bloch, MD, MS (1)

Results publications

PMID 27027204